1. Home
  2. ARMP vs NAGE Comparison

ARMP vs NAGE Comparison

Compare ARMP & NAGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Armata Pharmaceuticals Inc.

ARMP

Armata Pharmaceuticals Inc.

HOLD

Current Price

$5.45

Market Cap

295.5M

Sector

Health Care

ML Signal

HOLD

Logo Niagen Bioscience Inc.

NAGE

Niagen Bioscience Inc.

HOLD

Current Price

$3.44

Market Cap

269.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ARMP
NAGE
Founded
N/A
1999
Country
United States
United States
Employees
N/A
117
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Medicinal Chemicals and Botanical Products
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
295.5M
269.2M
IPO Year
1996
N/A

Fundamental Metrics

Financial Performance
Metric
ARMP
NAGE
Price
$5.45
$3.44
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
3
Target Price
$15.00
$16.00
AVG Volume (30 Days)
189.6K
663.8K
Earning Date
05-07-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$16.51
Revenue Next Year
N/A
$14.58
P/E Ratio
N/A
$21.29
Revenue Growth
N/A
N/A
52 Week Low
$2.14
$3.18
52 Week High
$14.98
$11.58

Technical Indicators

Market Signals
Indicator
ARMP
NAGE
Relative Strength Index (RSI) 32.23 46.97
Support Level $5.14 $3.35
Resistance Level $7.67 $3.57
Average True Range (ATR) 0.71 0.14
MACD -0.09 0.03
Stochastic Oscillator 1.57 68.75

Price Performance

Historical Comparison
ARMP
NAGE

About ARMP Armata Pharmaceuticals Inc.

Armata Pharmaceuticals Inc is a late clinical-stage biotechnology company focused on the development of high-purity and potent, pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using proprietary bacteriophage-based technology. It has completed three Phase 2 clinical trials to date. The Company operates and manages its business as one reportable operating segment, which is the business of developing pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat acute and chronic bacterial infections using its proprietary bacteriophage-based technology.

About NAGE Niagen Bioscience Inc.

Niagen Bioscience Inc is the leader in NAD+ (nicotinamide adenine dinucleotide) science and healthy-aging research. It is dedicated to advancing healthspan through precision science and innovative NAD+-boosting solutions. It is is clinically proven to increase NAD+ levels efficiently and effectively, and is the key ingredient powering our suite of Niagen brands.

Share on Social Networks: